Prominent players in the Cardiac Tissue Engineering market include, Terumo corporation (Japan), Artivion, Inc. (US), Baxter ...
Patients aged between 50 to 70 years with a mechanical heart valve replacement had better long-term survival compared to ...
Patients aged between 50 to 70 years with a mechanical heart valve replacement had better long-term survival compared to those with a biological valve, new research has found.
Every year, more than 5 million people in the U.S. are diagnosed with heart valve disease, but this condition has no ...
A promising new approach involves the use of Engineered Heart Muscle (EHM) allografts derived from Induced Pluripotent Stem Cells (iPSCs) to repair damaged hearts. The study, led by Ahmad-Fawad ...
Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart ...
Feb. 11, 2025 — Patients aged between 50 to 70 years with a mechanical heart valve replacement had better long-term survival compared to those with a biological valve, new research has ...
The last two decades have seen an increase in the use of biological over mechanical heart valve replacements. However, while ...